These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1728316

  • 21. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR.
    Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524
    [Abstract] [Full Text] [Related]

  • 22. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A, Martinelli G, Saglio G, Rosso C, Zaccaria A, Rosti G, Testoni N, Ambrosetti A, Izzi T, Sessarego M.
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A, Lion T, Kalhs P, Mitterbauer G, Henn T, Haas O, Födinger M, Kier P, Forstinger C, Quehenberger P.
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Gehly GB, Bryant EM, Lee AM, Kidd PG, Thomas ED.
    Blood; 1991 Jul 15; 78(2):458-65. PubMed ID: 2070081
    [Abstract] [Full Text] [Related]

  • 27. Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Snyder DS, Rossi JJ, Wang JL, Sniecinski IJ, Slovak ML, Wallace RB, Forman SJ.
    Transplantation; 1991 May 15; 51(5):1033-40. PubMed ID: 1674385
    [Abstract] [Full Text] [Related]

  • 28. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.
    Biol Blood Marrow Transplant; 2013 May 15; 19(5):735-40. PubMed ID: 23333776
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E, Krahl R, Thalmeier K, Helbig W.
    Exp Hematol; 1995 Dec 15; 23(14):1649-54. PubMed ID: 8542960
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Bingham EL, Ginsburg D.
    Blood; 1989 Aug 01; 74(2):882-5. PubMed ID: 2665860
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep 01; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 35. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1147-52. PubMed ID: 8971386
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia.
    Drobyski WR, Endean DJ, Klein JP, Hessner MJ.
    Br J Haematol; 1997 Aug 01; 98(2):458-66. PubMed ID: 9266951
    [Abstract] [Full Text] [Related]

  • 38. Detection by polymerase chain reaction of BCR/ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation.
    Bianchi C, Cairoli R, Marenco P, Muti G, Del Monte U, Perego RA.
    Eur J Cancer; 1995 Aug 01; 31A(2):197-201. PubMed ID: 7718325
    [Abstract] [Full Text] [Related]

  • 39. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ, Phillips CN, Winton EF, Farhi DC.
    Am J Clin Pathol; 1996 Jun 01; 105(6):756-60. PubMed ID: 8659451
    [Abstract] [Full Text] [Related]

  • 40. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J, Castillejo JA, Jiménez A, Maldonado J, Torres A.
    Med Clin (Barc); 1999 Dec 11; 113(20):779-82. PubMed ID: 10680143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.